Literature DB >> 21159594

High leg salvage rate after infrainguinal bypass surgery for ischemic tissue loss (Fontaine IV) is compromised by the short life expectancy.

M Söderström1, E Arvela, P S Aho, M Lepäntalo, A Albäck.   

Abstract

BACKGROUND AND AIMS: Most studies analysing the prognosis of infrainguinal bypass surgery (IBS) in patients with critical leg ischemia (CLI) have combined the outcome of patients with rest pain and tissue loss. The aim of the present study was to evaluate amputation-free survival (AFS) after IBS in patients with the most advanced form of peripheral arterial disease, CLI with tissue loss (Fontaine IV), and to analyse the risk factors for an adverse outcome. PATIENTS AND METHODS: 636 patients with CLI and tissue loss who underwent unilateral IBS between January 2000 and December 2006 at our institution were included in this retrospective study.
RESULTS: At one year, the leg salvage, survival and amputation-free survival rates were 83%, 71% and 55%, respectively, and at five years 76%, 38% and 30%, respectively. In univariate analysis, diabetes was associated with decreased AFS. In multivariate analysis, age, coronary artery disease, chronic pulmonary disease, gangrene and renal insufficiency were independent risk factors for decreased AFS.
CONCLUSION: Infrainguinal bypass grafting results in a high rate of leg salvage. Amputation-free survival was low during the follow-up due to the high mortality of patients with CLI and tissue loss. Several co-morbidities of the CLI patients were associated with decreased amputation-free survival.

Entities:  

Mesh:

Year:  2010        PMID: 21159594     DOI: 10.1177/145749691009900410

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  1 in total

1.  Validation of the Risk Score of the Mortality and Lower Limb Loss Considering Ambulatory Status after Surgical Revascularization in Maintaining Patients with Dialysis.

Authors:  Haruto Yamazaki; Hisae Hayashi; Morio Kawamura; Ayana Sasaki; Eriko Kondo; Shinya Ito; Kenji Wakai
Journal:  Ann Vasc Dis       Date:  2017-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.